Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

The Next Web
Read full post
Reid Hoffman has resigned from Microsoft's board to focus on leading Manus, an AI-driven drug discovery startup. This move marks his shift towards entrepreneurship in the AI healthcare sector.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare5 min read

​Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News